Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cold agglutinin disease revisited: a multinational, observational study of 232 patients.

Autor: Berentsen S; Department of Research and Innovation, Haugesund Hospital, Helse Fonna Hospital Trust, Haugesund, Norway., Barcellini W; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., D'Sa S; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Randen U; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Tvedt THA; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Fattizzo B; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Haukås E; Department of Blood and Cancer Diseases, Stavanger University Hospital, Stavanger, Norway., Kell M; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Brudevold R; Department of Medicine, Ålesund Hospital, Helse Møre og Romsdal Hopspital Trust, Ålesund, Norway., Dahm AEA; Department of Haematology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Dalgaard J; Department of Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Frøen H; Department of Medicine, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway., Hallstensen RF; Department of Medicine, Nordland Hospital, Bodø, Norway., Jæger PH; Department of Hematology, St Olav University Hospital, Trondheim, Norway.; Faculty of Medicine and Health Sciences and., Hjorth-Hansen H; Department of Hematology, St Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Małecka A; Department of Haematology and.; Department of Pathology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo Norway., Oksman M; Department of Internal Medicine, Turku City Hospital, Turku, Finland.; Department of Hematology and Stem Cell Transplantation, Turku University Hospital, Turku, Finland., Rolke J; Department of Medicine, Sørlandet Hospital, Kristiansand, Norway., Sekhar M; Haematology Department, Royal Free London NHS Foundation Trust, London, United Kingdom., Sørbø JH; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Norway; and., Tjønnfjord E; Department of Internal Medicine, Østfold Hospital Trust, Grålum, Norway., Tsykunova G; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Tjønnfjord GE; Department of Haematology and.; KG Jebsen Centre for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo Norway.

Publikováno v: Blood [Blood] 2020 Jul 23; Vol. 136 (4), pp. 480-488.

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.

Autor: Waage A; Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology, Trondheim, Norway. anders.waage@ntnu.no, Gimsing P, Fayers P, Abildgaard N, Ahlberg L, Björkstrand B, Carlson K, Dahl IM, Forsberg K, Gulbrandsen N, Haukås E, Hjertner O, Hjorth M, Karlsson T, Knudsen LM, Nielsen JL, Linder O, Mellqvist UH, Nesthus I, Rolke J, Strandberg M, Sørbø JH, Wisløff F, Juliusson G, Turesson I

Publikováno v: Blood [Blood] 2010 Sep 02; Vol. 116 (9), pp. 1405-12. Date of Electronic Publication: 2010 May 06.